세계의 남성형 탈모 치료 시장 보고서(2025년)

Androgenetic Alopecia Treatment Global Market Report 2025

US $ 4,490 ￦ 6,265,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,056,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,846,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

남성형 탈모 치료 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 7.5%로 33억 달러로 성장할 것으로 예상됩니다. 예측 기간의 성장은 탈모의 이환율 상승, 암, 다낭성 난소 증후군(PCOS), 류마티스 관절염 등의 만성 질환의 유행, 탈모의 고민에 대처하는 효과적인 솔루션에 대한 수요에 기인한다고 생각됩니다. 예측 기간의 주요 동향에는 제휴, 제품 승인, 투자 및 연구 개발이 포함됩니다.

탈모증 환자 증가는 향후 남성형 탈모 치료 시장의 성장을 견인할 것으로 예측됩니다. 탈모증(탈모)은 두피와 신체의 다른 부분에서 모발이 부분적으로 또는 완전히 손실되는 것을 의미합니다. 탈모의 원인으로는 영양 부족, 호르몬 변동, 유전적 소인, 스트레스 수준 상승 등이 있습니다. 남성형 탈모 치료는 호르몬 조절, 모낭 자극, 수술 개입 등 다양한 방법을 사용하여 탈모를 관리하고 발모를 촉진합니다. 예를 들어 미국에 본사를 둔 단체인 모발협회가 2022년 3월에 보고한 것처럼 세계에서는 약 2,100만명의 여성과 3,500만명의 남성이 탈모의 영향을 받고 있습니다. 또한 영국 정부 기관인 국민보건서비스에 따르면 2024년에는 영국에서 약 800만명의 여성과 650만명의 남성이 탈모를 경험하고 있습니다. 또한 연간 65만 건 이상의 모발 이식이 진행되고 있습니다. 따라서 탈모증 증가는 남성형 탈모 치료 시장을 추진하고 있습니다.

남성형 탈모 치료 시장의 주요 기업은 탈모에 대처하기 위해 혁신적인 약물 옵션을 적극적으로 개발하고 있습니다. 예를 들어, 2023년 6월, 미국 의료기관인 화이자는 12세 이상의 심각한 원형 탈모증 환자를 대상으로 하루에 한 번 투여한 경구 치료제인 리토푸로(리토르시티닙)의 FDA 승인을 발표했습니다. LITFULO는 야누스 키나아제 3(JAK3) 및 간세포 암에서 발현되는 티로신 키나아제(TEC) 패밀리를 표적으로하는 키나아제 억제제입니다. 환자의 23%가 6개월 후 80% 이상의 두피 모발 회복률을 달성한 반면 위약에서는 1.6%에 불과했습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염, 그리고 경기 회복이 시장에 미치는 영향을 포함한 거시 경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계 남성형 탈모 치료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계 남성형 탈모 치료 시장 : 성장률 분석
• 세계 남성형 탈모 치료 시장 실적 : 규모와 성장, 2019-2024
• 세계 남성형 탈모 치료 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 남성형 탈모 치료 전체 시장 규모(TAM)

제6장 시장 세분화

• 세계의 남성형 탈모 치료 시장 : 치료유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 의약품
• 디바이스
• 세계의 남성형 탈모 치료 시장 : 약유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 처방전
• 매장
• 세계의 남성형 탈모 치료 시장 : 성별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 남자
• 여성
• 세계의 남성형 탈모 치료 시장 : 최종 사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 재택 케어 설정
• 피부과
• 클리닉
• 기타 최종 사용자
• 세계의 남성형 탈모 치료 시장 : 의약품별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 경구약(피나스테리드)
• 외용약(미녹시딜)
• 호르몬 요법
• 세계의 남성형 탈모 치료 시장 : 디바이스유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 레이저 치료기
• 모발 이식 기기
• 두피 마이크로피그멘테이션 디바이스

제7장 지역별, 국가별 분석

• 세계 남성형 탈모 치료 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 세계 남성형 탈모 치료 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

• 남성형 탈모 치료 시장 : 경쟁 구도
• 남성형 탈모 치료 시장 : 기업 프로파일
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • Daiichi-Sankyo Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업 및 혁신 기업

• Sun Pharmaceutical Industries Ltd.
• Allergan Plc
• Aurobindo Pharma Limited
• Dr. Reddy's Laboratories Ltd.
• Cipla Limited
• Fagron Inc.
• Vitabiotics Ltd.
• Cosmo Pharmaceuticals NV
• Aclaris Therapeutics Inc.
• Curallux LLC
• PureTech Health
• Technoderma Medicines Inc.
• Theradome Inc.
• Lexington International
• HCell Inc.

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

• 남성형 탈모 치료 시장(2029년) : 새로운 기회를 제공하는 국가
• 남성형 탈모 치료 시장(2029년) : 새로운 기회를 제공하는 부문
• 남성형 탈모 치료 시장(2029년) : 성장 전략
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제36장 부록

SHW

영문 목차

영문목차

Androgenetic alopecia, also referred to as male-pattern baldness or female-pattern hair loss, is a prevalent form of hair loss affecting both men and women. It is characterized by a gradual thinning of the hair, commonly starting with a receding hairline in men and diffuse thinning over the crown in women. Genetic factors and the presence of androgens, particularly dihydrotestosterone (DHT), play significant roles in this condition.

The primary treatments for androgenetic alopecia include pharmaceuticals and devices. Pharmaceuticals encompass substances used in healthcare, typically medicinal drugs or chemical compounds. These medications are available in both prescription and over-the-counter forms and are utilized by both males and females. They find applications in various end-user industries, including homecare settings, dermatology, clinics, and others.

The androgenetic alopecia treatment market research report is one of a series of new reports from The Business Research Company that provides androgenetic alopecia treatment market statistics, including androgenetic alopecia treatment industry global market size, regional shares, competitors with an androgenetic alopecia treatment market share, detailed androgenetic alopecia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the androgenetic alopecia treatment industry. This androgenetic alopecia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The androgenetic alopecia treatment market size has grown strongly in recent years. It will grow from $2.29 billion in 2024 to $2.47 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to emphasis on improving patient outcomes and quality of life, increase in the geriatric population, increasing healthcare expenditure.

The androgenetic alopecia treatment market size is expected to see strong growth in the next few years. It will grow to $3.3 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to rising incidence of hair loss, prevalence of chronic diseases such as cancer, polycystic ovary syndrome (PCOS), and rheumatoid arthritis, demand for effective solutions to address hair loss concerns. Major trends in the forecast period include partnerships, product approvals, investments, research and developments.

The increasing incidence of hair loss cases is projected to drive the growth of the androgenetic alopecia treatment market in the future. Alopecia, or hair loss, refers to the partial or complete loss of hair from the scalp or other parts of the body. Causes of hair loss include nutritional deficiencies, hormonal fluctuations, genetic predispositions, and heightened stress levels. Androgenetic alopecia treatments employ various methods, including hormonal regulation, follicle stimulation, and surgical interventions, to manage hair loss and stimulate regrowth. For example, as reported in March 2022 by the Hair Society, an organization based in the US, approximately 21 million women and 35 million men worldwide are affected by hair loss. Additionally, in 2024, according to the National Health Service, a government agency in the UK, around 8 million women and 6.5 million men in the UK experience hair loss. Moreover, over 650,000 hair transplants are performed annually. Hence, the increasing prevalence of hair loss cases propels the androgenetic alopecia treatment market.

Key players in the androgenetic alopecia treatment market are actively developing innovative drug options to address hair loss. These options target mechanisms such as promoting hair follicle regeneration, inhibiting hormones responsible for hair loss, and utilizing novel delivery systems such as topical treatments and oral medications. For instance, in June 2023, Pfizer Inc., a healthcare company based in the US, announced the FDA approval of LITFULO (ritlecitinib), a once-daily oral treatment for individuals aged 12 and above with severe alopecia areata. LITFULO is a kinase inhibitor that targets Janus kinase 3 (JAK3) and the tyrosine kinase expressed in hepatocellular carcinoma (TEC) family of kinases. The FDA approval was based on the ALLEGRO Phase 2b/3 trial, where 23% of patients treated with LITFULO 50mg achieved 80% or more scalp hair coverage after six months, compared to 1.6% with placebo. This solution offers a new option for individuals experiencing significant hair loss, addressing a previously unmet need in alopecia areata treatment.

In April 2023, Marksans Pharma, an India-based pharmaceutical company, acquired a manufacturing facility from Tevapharm India for an undisclosed sum. This strategic acquisition enabled Marksans Pharma to double its existing manufacturing capacity in India and broaden its product range to include tablets, capsules, ointments, liquids, and creams. Teva Pharmaceuticals, based in Israel, provides treatments for androgenetic alopecia.

Major companies operating in the androgenetic alopecia treatment market are Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Eli Lilly and Company, Daiichi-Sankyo Co. Ltd., Sun Pharmaceutical Industries Ltd., Allergan Plc, Aurobindo Pharma Limited, Dr Reddy's Laboratories Ltd., Cipla Limited, Fagron Inc., Vitabiotics Ltd., Cosmo Pharmaceuticals NV, Aclaris Therapeutics Inc., Curallux LLC, PureTech Health, Technoderma Medicines Inc., Theradome Inc., Lexington International, HCell Inc., Follica Inc., Ranbaxy Laboratories Ltd., Apira Science Inc., Freedom Laser Therapy Inc., Histogen Inc.

North America was the largest region in the androgenetic alopecia treatment market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the androgenetic alopecia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the androgenetic alopecia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The androgenetic alopecia treatment market consists of sales of microneedling devices, hair growth vitamins, and supplements. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Androgenetic Alopecia Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on androgenetic alopecia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for androgenetic alopecia treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The androgenetic alopecia treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Pharmaceutical; Device
• 2) By Medication Type: Prescription; Over-The-Counter
• 3) By Gender: Male; Female
• 4) By End-User: Homecare Settings; Dermatology; Clinics; Other End-Users
• Subsegments:
• 1) By Pharmaceutical: Oral Medications ( Finasteride); Topical Medications (Minoxidil); Hormonal Therapy
• 2) By Device: Laser Therapy Devices; Hair Transplant Devices; Scalp Micropigmentation Devices
• Companies Mentioned: Johnson & Johnson; Merck & Co. Inc.; AbbVie Inc.; Eli Lilly and Company; Daiichi-Sankyo Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Androgenetic Alopecia Treatment Market Characteristics

3. Androgenetic Alopecia Treatment Market Trends And Strategies

4. Androgenetic Alopecia Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Androgenetic Alopecia Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Androgenetic Alopecia Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Androgenetic Alopecia Treatment Market Growth Rate Analysis
• 5.4. Global Androgenetic Alopecia Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Androgenetic Alopecia Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Androgenetic Alopecia Treatment Total Addressable Market (TAM)

6. Androgenetic Alopecia Treatment Market Segmentation

• 6.1. Global Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical
• Device
• 6.2. Global Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prescription
• Over-The-Counter
• 6.3. Global Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Male
• Female
• 6.4. Global Androgenetic Alopecia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Homecare Settings
• Dermatology
• Clinics
• Other End-Users
• 6.5. Global Androgenetic Alopecia Treatment Market, Sub-Segmentation Of Pharmaceutical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Medications (Finasteride)
• Topical Medications (Minoxidil)
• Hormonal Therapy
• 6.6. Global Androgenetic Alopecia Treatment Market, Sub-Segmentation Of Device, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laser Therapy Devices
• Hair Transplant Devices
• Scalp Micropigmentation Devices

7. Androgenetic Alopecia Treatment Market Regional And Country Analysis

• 7.1. Global Androgenetic Alopecia Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Androgenetic Alopecia Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Androgenetic Alopecia Treatment Market

• 8.1. Asia-Pacific Androgenetic Alopecia Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Androgenetic Alopecia Treatment Market

• 9.1. China Androgenetic Alopecia Treatment Market Overview
• 9.2. China Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Androgenetic Alopecia Treatment Market

• 10.1. India Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Androgenetic Alopecia Treatment Market

• 11.1. Japan Androgenetic Alopecia Treatment Market Overview
• 11.2. Japan Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Androgenetic Alopecia Treatment Market

• 12.1. Australia Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Androgenetic Alopecia Treatment Market

• 13.1. Indonesia Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Androgenetic Alopecia Treatment Market

• 14.1. South Korea Androgenetic Alopecia Treatment Market Overview
• 14.2. South Korea Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Androgenetic Alopecia Treatment Market

• 15.1. Western Europe Androgenetic Alopecia Treatment Market Overview
• 15.2. Western Europe Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Androgenetic Alopecia Treatment Market

• 16.1. UK Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Androgenetic Alopecia Treatment Market

• 17.1. Germany Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Androgenetic Alopecia Treatment Market

• 18.1. France Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Androgenetic Alopecia Treatment Market

• 19.1. Italy Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Androgenetic Alopecia Treatment Market

• 20.1. Spain Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Androgenetic Alopecia Treatment Market

• 21.1. Eastern Europe Androgenetic Alopecia Treatment Market Overview
• 21.2. Eastern Europe Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Androgenetic Alopecia Treatment Market

• 22.1. Russia Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Androgenetic Alopecia Treatment Market

• 23.1. North America Androgenetic Alopecia Treatment Market Overview
• 23.2. North America Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Androgenetic Alopecia Treatment Market

• 24.1. USA Androgenetic Alopecia Treatment Market Overview
• 24.2. USA Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Androgenetic Alopecia Treatment Market

• 25.1. Canada Androgenetic Alopecia Treatment Market Overview
• 25.2. Canada Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Androgenetic Alopecia Treatment Market

• 26.1. South America Androgenetic Alopecia Treatment Market Overview
• 26.2. South America Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Androgenetic Alopecia Treatment Market

• 27.1. Brazil Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Androgenetic Alopecia Treatment Market

• 28.1. Middle East Androgenetic Alopecia Treatment Market Overview
• 28.2. Middle East Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Androgenetic Alopecia Treatment Market

• 29.1. Africa Androgenetic Alopecia Treatment Market Overview
• 29.2. Africa Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Androgenetic Alopecia Treatment Market Competitive Landscape And Company Profiles

• 30.1. Androgenetic Alopecia Treatment Market Competitive Landscape
• 30.2. Androgenetic Alopecia Treatment Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Daiichi-Sankyo Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Androgenetic Alopecia Treatment Market Other Major And Innovative Companies

• 31.1. Sun Pharmaceutical Industries Ltd.
• 31.2. Allergan Plc
• 31.3. Aurobindo Pharma Limited
• 31.4. Dr. Reddy's Laboratories Ltd.
• 31.5. Cipla Limited
• 31.6. Fagron Inc.
• 31.7. Vitabiotics Ltd.
• 31.8. Cosmo Pharmaceuticals NV
• 31.9. Aclaris Therapeutics Inc.
• 31.10. Curallux LLC
• 31.11. PureTech Health
• 31.12. Technoderma Medicines Inc.
• 31.13. Theradome Inc.
• 31.14. Lexington International
• 31.15. HCell Inc.

32. Global Androgenetic Alopecia Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Androgenetic Alopecia Treatment Market

34. Recent Developments In The Androgenetic Alopecia Treatment Market

35. Androgenetic Alopecia Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Androgenetic Alopecia Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Androgenetic Alopecia Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Androgenetic Alopecia Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료